{"count": 9, "results": [{"_id": "36230715", "pmid": 36230715, "pmcid": "PMC9563053", "title": "Modulation of Plasma Lipidomic Profiles in Metastatic Castration-Resistant Prostate Cancer by Simvastatin", "journal": "Cancers (Basel)", "authors": ["Mak B", "Lin HM", "Duong T", "Mahon KL", "Joshua AM", "Stockler MR", "Gurney H", "Parnis F", "Zhang A", "Scheinberg T", "Wittert G", "Butler LM", "Sullivan D", "Hoy AJ", "Meikle PJ", "Horvath LG"], "date": "2022-09-30T00:00:00Z", "doi": "10.3390/cancers14194792", "meta_date_publication": "2022 Sep 30", "meta_volume": "14", "meta_issue": "19", "meta_pages": "", "score": 50277.8, "text_hl": "Twenty-seven @SPECIES_9606 @@@men@@@ with @<m>DISEASE_Prostatic_Neoplasms_Castration_Resistant</m> @DISEASE_MESH:D064129 @@@mCRPC@@@ were given @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ together with their standard treatment for 12 weeks. ", "citations": {"NLM": "Mak B, Lin HM, Duong T, Mahon KL, Joshua AM, Stockler MR, Gurney H, Parnis F, Zhang A, Scheinberg T, Wittert G, Butler LM, Sullivan D, Hoy AJ, Meikle PJ, Horvath LG. Modulation of Plasma Lipidomic Profiles in Metastatic Castration-Resistant Prostate Cancer by Simvastatin Cancers (Basel). 2022 Sep 30;14(19):. PMID: 36230715", "BibTeX": "@article{36230715, title={Modulation of Plasma Lipidomic Profiles in Metastatic Castration-Resistant Prostate Cancer by Simvastatin}, author={Mak B and Lin HM and Duong T and Mahon KL and Joshua AM and Stockler MR and Gurney H and Parnis F and Zhang A and Scheinberg T and Wittert G and Butler LM and Sullivan D and Hoy AJ and Meikle PJ and Horvath LG}, journal={Cancers (Basel)}, volume={14}, number={19}}"}}, {"_id": "34843630", "pmid": 34843630, "title": "Combination therapy with novel androgen receptor antagonists and statin for castration-resistant prostate cancer.", "journal": "Prostate", "authors": ["Nakayama H", "Sekine Y", "Oka D", "Miyazawa Y", "Arai S", "Koike H", "Matsui H", "Shibata Y", "Suzuki K"], "date": "2022-02-01T00:00:00Z", "doi": "10.1002/pros.24274", "meta_date_publication": "2022 Feb", "meta_volume": "82", "meta_issue": "3", "meta_pages": "314-322", "score": 50272.9, "text_hl": "In this study, we investigated a combination therapy of novel AR antagonists and statin, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, for @<m>DISEASE_Prostatic_Neoplasms_Castration_Resistant</m> @DISEASE_MESH:D064129 @@@CRPC@@@. ", "citations": {"NLM": "Nakayama H, Sekine Y, Oka D, Miyazawa Y, Arai S, Koike H, Matsui H, Shibata Y, Suzuki K. Combination therapy with novel androgen receptor antagonists and statin for castration-resistant prostate cancer. Prostate. 2022 Feb;82(3):314-322. PMID: 34843630", "BibTeX": "@article{34843630, title={Combination therapy with novel androgen receptor antagonists and statin for castration-resistant prostate cancer.}, author={Nakayama H and Sekine Y and Oka D and Miyazawa Y and Arai S and Koike H and Matsui H and Shibata Y and Suzuki K}, journal={Prostate}, volume={82}, number={3}, pages={314-322}}"}}, {"_id": "33032653", "pmid": 33032653, "pmcid": "PMC7545949", "title": "Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition", "journal": "J Exp Clin Cancer Res", "authors": ["Iannelli F", "Roca MS", "Lombardi R", "Ciardiello C", "Grumetti L", "De Rienzo S", "Moccia T", "Vitagliano C", "Sorice A", "Costantini S", "Milone MR", "Pucci B", "Leone A", "Di Gennaro E", "Mancini R", "Ciliberto G", "Bruzzese F", "Budillon A"], "date": "2020-10-08T00:00:00Z", "doi": "10.1186/s13046-020-01723-7", "meta_date_publication": "2020 Oct 8", "meta_volume": "39", "meta_issue": "1", "meta_pages": "213", "score": 50257.797, "text_hl": "Herein we report the synergistic antitumor interaction between two well-known drugs used for years in clinical practice, the antiepileptic agent with histone deacetylase inhibitory activity @CHEMICAL_Valproic_Acid @CHEMICAL_MESH:D014635 @@@valproic acid@@@ and the @CHEMICAL_Cholesterol @CHEMICAL_MESH:D002784 @@@cholesterol@@@ lowering agent @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, in @<m>DISEASE_Prostatic_Neoplasms_Castration_Resistant</m> @DISEASE_MESH:D064129 @@@mCRPC@@@ models.", "citations": {"NLM": "Iannelli F, Roca MS, Lombardi R, Ciardiello C, Grumetti L, De Rienzo S, Moccia T, Vitagliano C, Sorice A, Costantini S, Milone MR, Pucci B, Leone A, Di Gennaro E, Mancini R, Ciliberto G, Bruzzese F, Budillon A. Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition J Exp Clin Cancer Res. 2020 Oct 8;39(1):213. PMID: 33032653", "BibTeX": "@article{33032653, title={Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition}, author={Iannelli F and Roca MS and Lombardi R and Ciardiello C and Grumetti L and De Rienzo S and Moccia T and Vitagliano C and Sorice A and Costantini S and Milone MR and Pucci B and Leone A and Di Gennaro E and Mancini R and Ciliberto G and Bruzzese F and Budillon A}, journal={J Exp Clin Cancer Res}, volume={39}, number={1}, pages={213}}"}}, {"_id": "33897882", "pmid": 33897882, "pmcid": "PMC8058714", "title": "MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer", "journal": "Theranostics", "authors": ["Li Q", "Wang M", "Hu Y", "Zhao E", "Li J", "Ren L", "Wang M", "Xu Y", "Liang Q", "Zhang D", "Lai Y", "Liu S", "Peng X", "Zhu C", "Ye L"], "date": "2021-03-31T00:00:00Z", "doi": "10.7150/thno.56604", "meta_date_publication": "2021", "meta_volume": "11", "meta_issue": "12", "meta_pages": "5794-5812", "score": 50246.586, "text_hl": "Importantly, targeting @GENE_MYBL2 @GENE_4605 @@@MYBL2@@@, or treatment with either the @GENE_YAP1 @GENE_10413 @@@YAP@@@/@GENE_TAZ @GENE_6901 @@@TAZ@@@ inhibitor @CHEMICAL_Verteporfin @CHEMICAL_MESH:D000077362 @@@Verteporfin@@@ or the @GENE_RHOA @GENE_387 @@@RhoA@@@ inhibitor @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@, reversed the resistance to @DISEASE_Virilism @DISEASE_MESH:D014770 @@@ADT@@@ and blocked @DISEASE_Neoplasm_Metastasis @DISEASE_MESH:D009362 @@@bone metastasis@@@ in @<m>DISEASE_Prostatic_Neoplasms_Castration_Resistant</m> @DISEASE_MESH:D064129 @@@CRPC@@@ cells. ", "citations": {"NLM": "Li Q, Wang M, Hu Y, Zhao E, Li J, Ren L, Wang M, Xu Y, Liang Q, Zhang D, Lai Y, Liu S, Peng X, Zhu C, Ye L. MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer Theranostics. 2021;11(12):5794-5812. PMID: 33897882", "BibTeX": "@article{33897882, title={MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer}, author={Li Q and Wang M and Hu Y and Zhao E and Li J and Ren L and Wang M and Xu Y and Liang Q and Zhang D and Lai Y and Liu S and Peng X and Zhu C and Ye L}, journal={Theranostics}, volume={11}, number={12}, pages={5794-5812}}"}}, {"_id": "28910332", "pmid": 28910332, "pmcid": "PMC5599006", "title": "Concurrent treatment with simvastatin and NF-kappaB inhibitor in human castration-resistant prostate cancer cells exerts synergistic anti-cancer effects via control of the NF-kappaB/LIN28/let-7 miRNA signaling pathway", "journal": "PLoS One", "authors": ["Kang M", "Lee KH", "Lee HS", "Jeong CW", "Ku JH", "Kim HH", "Kwak C"], "date": "2017-09-14T00:00:00Z", "doi": "10.1371/journal.pone.0184644", "meta_date_publication": "2017", "meta_volume": "12", "meta_issue": "9", "meta_pages": "e0184644", "score": 50093.94, "text_hl": "More importantly, the downregulated let-7 miRNA family expression in @SPECIES_9606 @@@human@@@ @<m>DISEASE_Prostatic_Neoplasms_Castration_Resistant</m> @DISEASE_MESH:D064129 @@@CRPC@@@ cells increased after treatment with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (Fig 2B-c). ", "citations": {"NLM": "Kang M, Lee KH, Lee HS, Jeong CW, Ku JH, Kim HH, Kwak C. Concurrent treatment with simvastatin and NF-kappaB inhibitor in human castration-resistant prostate cancer cells exerts synergistic anti-cancer effects via control of the NF-kappaB/LIN28/let-7 miRNA signaling pathway PLoS One. 2017;12(9):e0184644. PMID: 28910332", "BibTeX": "@article{28910332, title={Concurrent treatment with simvastatin and NF-kappaB inhibitor in human castration-resistant prostate cancer cells exerts synergistic anti-cancer effects via control of the NF-kappaB/LIN28/let-7 miRNA signaling pathway}, author={Kang M and Lee KH and Lee HS and Jeong CW and Ku JH and Kim HH and Kwak C}, journal={PLoS One}, volume={12}, number={9}, pages={e0184644}}"}}, {"_id": "24666612", "pmid": 24666612, "pmcid": "PMC3987159", "title": "Effect of simvastatin on castration-resistant prostate cancer cells", "journal": "Lipids Health Dis", "authors": ["Kim JH", "Cox ME", "Wasan KM"], "date": "2014-03-26T00:00:00Z", "doi": "10.1186/1476-511X-13-56", "meta_date_publication": "2014 Mar 26", "meta_volume": "13", "meta_issue": "", "meta_pages": "56", "score": 50077.336, "text_hl": "It would be worthwhile to investigate the inhibition of multiple @CHEMICAL_Cholesterol @CHEMICAL_MESH:D002784 @@@cholesterol@@@ regulatory pathways including @CHEMICAL_Cholesterol @CHEMICAL_MESH:D002784 @@@cholesterol@@@ influx and synthesis using combination treatment of @GENE_SCARB1 @GENE_949 @@@SR-BI@@@ silencing and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ to assess the effect of a combination treatment in @<m>DISEASE_Prostatic_Neoplasms_Castration_Resistant</m> @DISEASE_MESH:D064129 @@@CRPC@@@ models.", "citations": {"NLM": "Kim JH, Cox ME, Wasan KM. Effect of simvastatin on castration-resistant prostate cancer cells Lipids Health Dis. 2014 Mar 26;13():56. PMID: 24666612", "BibTeX": "@article{24666612, title={Effect of simvastatin on castration-resistant prostate cancer cells}, author={Kim JH and Cox ME and Wasan KM}, journal={Lipids Health Dis}, volume={13}, pages={56}}"}}, {"_id": "25122066", "pmid": 25122066, "title": "Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer.", "journal": "Mol Cancer Ther", "authors": ["Babcook MA", "Shukla S", "Fu P", "Vazquez EJ", "Puchowicz MA", "Molter JP", "Oak CZ", "MacLennan GT", "Flask CA", "Lindner DJ", "Parker Y", "Daneshgari F", "Gupta S"], "date": "2014-10-01T00:00:00Z", "doi": "10.1158/1535-7163.MCT-14-0451", "meta_date_publication": "2014 Oct", "meta_volume": "13", "meta_issue": "10", "meta_pages": "2288-302", "score": 50070.504, "text_hl": "Synergistic @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ combination chemotherapy for osseous metastatic @<m>DISEASE_Prostatic_Neoplasms_Castration_Resistant</m> @DISEASE_MESH:D064129 @@@castration-resistant prostate cancer@@@.", "citations": {"NLM": "Babcook MA, Shukla S, Fu P, Vazquez EJ, Puchowicz MA, Molter JP, Oak CZ, MacLennan GT, Flask CA, Lindner DJ, Parker Y, Daneshgari F, Gupta S. Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer. Mol Cancer Ther. 2014 Oct;13(10):2288-302. PMID: 25122066", "BibTeX": "@article{25122066, title={Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer.}, author={Babcook MA and Shukla S and Fu P and Vazquez EJ and Puchowicz MA and Molter JP and Oak CZ and MacLennan GT and Flask CA and Lindner DJ and Parker Y and Daneshgari F and Gupta S}, journal={Mol Cancer Ther}, volume={13}, number={10}, pages={2288-302}}"}}, {"_id": "31081050", "pmid": 31081050, "pmcid": "PMC6521936", "title": "Simvastatin delays castration-resistant prostate cancer metastasis and androgen receptor antagonist resistance by regulating the expression of caveolin-1", "journal": "Int J Oncol", "authors": ["Gao Y", "Li L", "Li T", "Ma L", "Yuan M", "Sun W", "Cheng HL", "Niu L", "Du Z", "Quan Z", "Fan Y", "Fan J", "Luo C", "Wu X"], "date": "2019-06-01T00:00:00Z", "doi": "10.3892/ijo.2019.4774", "meta_date_publication": "2019 Jun", "meta_volume": "54", "meta_issue": "6", "meta_pages": "2054-2068", "score": 50064.57, "text_hl": "Finally, to explore whether @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ exerts antitumor effects on @<m>DISEASE_Prostatic_Neoplasms_Castration_Resistant</m> @DISEASE_MESH:D064129 @@@CRPC@@@, cell viability was evaluated by a CCK-8 assay in cells treated with various concentrations of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@. ", "citations": {"NLM": "Gao Y, Li L, Li T, Ma L, Yuan M, Sun W, Cheng HL, Niu L, Du Z, Quan Z, Fan Y, Fan J, Luo C, Wu X. Simvastatin delays castration-resistant prostate cancer metastasis and androgen receptor antagonist resistance by regulating the expression of caveolin-1 Int J Oncol. 2019 Jun;54(6):2054-2068. PMID: 31081050", "BibTeX": "@article{31081050, title={Simvastatin delays castration-resistant prostate cancer metastasis and androgen receptor antagonist resistance by regulating the expression of caveolin-1}, author={Gao Y and Li L and Li T and Ma L and Yuan M and Sun W and Cheng HL and Niu L and Du Z and Quan Z and Fan Y and Fan J and Luo C and Wu X}, journal={Int J Oncol}, volume={54}, number={6}, pages={2054-2068}}"}}, {"_id": "25412314", "pmid": 25412314, "pmcid": "PMC4260755", "title": "Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells", "journal": "Cell Death Dis", "authors": ["Babcook MA", "Sramkoski RM", "Fujioka H", "Daneshgari F", "Almasan A", "Shukla S", "Nanavaty RR", "Gupta S"], "date": "2014-11-20T00:00:00Z", "doi": "10.1038/cddis.2014.500", "meta_date_publication": "2014 Nov 20", "meta_volume": "5", "meta_issue": "11", "meta_pages": "e1536", "score": 50063.066, "text_hl": "...@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SIM@@@+@GENE_SLTM @GENE_79811 @@@MET@@@ treatment does not induce apoptosis in @<m>DISEASE_Prostatic_Neoplasms_Castration_Resistant</m> @DISEASE_MESH:D064129 @@@CRPC@@@ cells", "citations": {"NLM": "Babcook MA, Sramkoski RM, Fujioka H, Daneshgari F, Almasan A, Shukla S, Nanavaty RR, Gupta S. Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells Cell Death Dis. 2014 Nov 20;5(11):e1536. PMID: 25412314", "BibTeX": "@article{25412314, title={Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells}, author={Babcook MA and Sramkoski RM and Fujioka H and Daneshgari F and Almasan A and Shukla S and Nanavaty RR and Gupta S}, journal={Cell Death Dis}, volume={5}, number={11}, pages={e1536}}"}}]}